The role of lysine residue at amino acid position 165 of human immunodeficiency virus type 1 CRF01_AE Gag in reducing viral drug susceptibility to protease inhibitors-Reference-Cited by-同舟云学术

The role of lysine residue at amino acid position 165 of human immunodeficiency virus type 1 CRF01_AE Gag in reducing viral drug susceptibility to protease inhibitors

Published:2010-09 Issue:1 Volume:405 Page:129-138
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Kameoka Masanori,Isarangkura-na-ayuthaya Panasda,Kameoka Yoko,Sapsutthipas Sompong,Soonthornsata Bongkot,Nakamura Shota,Tokunaga Kenzo,Sawanpanyalert Pathom,Ikuta Kazuyoshi,Auwanit Wattana

Funder

Ministry of Education, Cultures, Sports, Science and Technology (MEXT) of Japan

Department of Medical Sciences, Ministry of Public Health of Thailand

Publisher

Elsevier BV

Subject

Virology

Reference38 articles.

1. Selected amino acid substitutions in the C-terminal region of human immunodeficiency virus type 1 capsid protein affect virus assembly and release;Abdurahman;J. Gen. Virol.,2004

2. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone;Adachi;J. Virol.,1986

3. Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors;Bally;AIDS Res. Hum. Retroviruses,2000

4. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1;Barrie;Virology,1996

5. In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor;Carrillo;J. Virol.,1998

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contribution of Gag and protease to variation in susceptibility to protease inhibitors between different strains of subtype B human immunodeficiency virus type 1;Journal of General Virology;2014-01-01

2. Three Residues in HIV-1 Matrix Contribute to Protease Inhibitor Susceptibility and Replication Capacity;Antimicrobial Agents and Chemotherapy;2011-03